Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Apply
MM-398 & Cyclophosphamide
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step